Recombinant Anti-SOX9 Antibody [rSOX9/2288] (A277921)

Anti-SOX9 Antibody [rSOX9/2288]

Recombinant mouse monoclonal [rSOX9/2288] antibody to SOX9.

The specificity of this monoclonal antibody to its intended target was validated by HuProtTMArray, containing more than 19,000 full-length human proteins. Plays an important role in the normal skeletal development. May regulate the expression of other genes involved in chondrogenesis by acting as a transcription factor for these genes. Nucleus (Potential). Campomelic dysplasia (CMD1) [MIM:114290]: Rare, often lethal, dominantly inherited, congenital osteo-chondrodysplasia, associated with male-to-female autosomal sex reversal in two-thirds of the affected karyotypic males. A disease of the newborn characterized by congenital bowing and angulation of long bones, unusually small scapulae, deformed pelvis and spine and a missing pair of ribs. Craniofacial defects such as cleft palate, micrognathia, flat face and hypertelorism are common.

IP, WB, IHC-P

IP: 2-4 µg/mg protein, WB: 1-2 µg/ml, IHC-P: 1-2 µg/ml

Human

Recombinant full-length human SOX9 protein.

Mouse

Monoclonal

rSOX9/2288

IgG1

Protein A/G chromatography.

200 µg/ml

56 kDa

Liquid

Supplied in 10mM Phosphate Buffered Saline with 0.05% BSA and 0.05% Sodium Azide.

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

This monoclonal antibody is also available in a different formulation without BSA and Sodium Azide - Anti-SOX9 Antibody [rSOX9/2288] - BSA and Azide free (A278509).

Transcription factor SOX-9